lt p gt InMed Pharmaceuticals Inc. is a pre clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual or combination of cannabinoids against disease targets a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all cannabinoids at pharmaceutical grade gt . purity and drug development program enabled by the two aforementioned tools. Leaders in the pipeline include a treatment for the symptoms and, potentially, the underlying disease in Epidermolysis Bullosa, a rare, devastating genetic skin disorder and, a once a day eyedrops formulation of cannabinoids to treat Glaucoma, one of the leading causes of blindness in the developed world.
Quote | InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF)
Last: | $4.96 |
---|---|
Change Percent: | -25.41% |
Open: | $5.4 |
Close: | $4.96 |
High: | $6.14 |
Low: | $4.87 |
Volume: | 42,042 |
Last Trade Date Time: | 11/10/2020 04:55:18 pm |
News | InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF)
Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...
InMed Announces Closing of US$4.5 Million Private Placement PR Newswire VANCOUVER, BC , Feb. 16 , 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medicat...
Message Board Posts | InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF)
Subject | By | Source | When |
---|---|---|---|
$INM InMed Pharmaceuticals Inc | mick | investorshub | 04/30/2023 9:09:42 PM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 04/15/2023 3:14:06 PM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 02/27/2023 12:08:56 AM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 02/06/2023 12:33:14 AM |
ZALMY SAYS $3 INCOMING!!!! IM SLAPPING EVERYTHING AH | PENNY DIPZ | investorshub | 02/03/2023 12:04:48 AM |
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
IMLFF Stock Symbol:
OTCMKTS Market:
InMed Announces Closing of US$4.5 Million Private Placement PR Newswire VANCOUVER, BC , Feb. 16 , 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medicat...
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 11, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company develo...
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 5, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing...